Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
about
Aptamers: A Feasible Technology in Cancer ImmunotherapyGeneration of Aptamers with an Expanded Chemical RepertoireProspects for nucleic acid-based therapeutics against hepatitis C virusUse of Aptamers as Diagnostics Tools and Antiviral Agents for Human VirusesPharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein.Aptamer-based therapeutics: new approaches to combat human viral diseasesCellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.Sponging of cellular proteins by viral RNAs.Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.Status and Prospects of Aptamers as Drug Components.Inducible Bcl-2 gene RNA interference mediated by aptamer-integrated HDV ribozyme switch.Hepatitis C virus infection stimulates transforming growth factor-β1 expression through up-regulating miR-192.A DNA aptamer efficiently inhibits the infectivity of Bovine herpesvirus 1 by blocking viral entry.Development of RNA aptamer that inhibits methyltransferase activity of dengue virus.Functional sequestration of microRNA-122 from Hepatitis C Virus by circular RNA sponges.Engineered Aptamers to Probe Molecular Interactions on the Cell Surface.
P2860
Q26740303-7C55971A-1627-48D7-8430-F4B32F63B391Q26782794-42CF5367-016F-4195-B140-AF0FCFCE4033Q26852368-965FAAB9-2BC7-4D8F-91F6-A7E7CA6EE006Q28079654-B4ED4602-4693-4229-BC11-EFFD1A7CBCB8Q36939736-85119602-12EE-43AE-AFCA-C5A15579E394Q37415958-45FB1F96-0F72-4875-87D3-CABDDBC7E50FQ37656119-467CF324-D7C1-4B8C-8FB4-82A5E220B0B9Q38252264-8A2D3E35-A7A7-429D-9321-541A0F0577E4Q38299435-BC1FC786-5686-48FA-890D-3434D0F6F848Q38488502-8BFC7914-1D7D-4410-B79D-2F7092F7409BQ40184024-5D5D0ADE-F719-4F84-8EF7-08BE5A22F492Q40634326-7979AA4F-D4DD-491F-BAEA-6EDD2F2403DAQ41718011-1AE6B36C-BA84-4727-831E-DDE081B635A9Q45325807-40F54719-1125-46D5-8679-45604ABCB38BQ52682787-DBC23D19-DAA4-482C-A117-1D131B44C27DQ53092802-AA49693E-6339-4E83-AD9C-891017A084AC
P2860
Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition of hepatitis C viru ...... gainst HCV NS5B RNA replicase.
@en
type
label
Inhibition of hepatitis C viru ...... gainst HCV NS5B RNA replicase.
@en
prefLabel
Inhibition of hepatitis C viru ...... gainst HCV NS5B RNA replicase.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of hepatitis C viru ...... gainst HCV NS5B RNA replicase.
@en
P2093
Chang Ho Lee
Gyu-Jeong Noh
Ji Hyun Kim
Jong Hoon Lim
Jung-Hye Kim
Seong-Wook Lee
Soo-Han Lee
Wonkyo Han
Young Ju Lee
P2860
P304
P356
10.1128/JVI.00405-13
P407
P577
2013-04-17T00:00:00Z